These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 29712495)
1. Development of a novel diagnostic algorithm to predict NASH in HCV-positive patients. Gallotta A; Paneghetti L; Mrázová V; Bednárová A; Kružlicová D; Frecer V; Miertus S; Biasiolo A; Martini A; Pontisso P; Fassina G Int J Biol Markers; 2018 May; 33(2):231-236. PubMed ID: 29712495 [TBL] [Abstract][Full Text] [Related]
2. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients. Martini A; Fattovich G; Guido M; Bugianesi E; Biasiolo A; Ieluzzi D; Gallotta A; Fassina G; Merkel C; Gatta A; Negro F; Pontisso P J Viral Hepat; 2015 Oct; 22(10):800-8. PubMed ID: 25611978 [TBL] [Abstract][Full Text] [Related]
3. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy. Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052 [TBL] [Abstract][Full Text] [Related]
4. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity. Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726 [TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time? Montagnana M; Danese E; Lippi G Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050 [TBL] [Abstract][Full Text] [Related]
6. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis. Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440 [TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222 [TBL] [Abstract][Full Text] [Related]
8. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients. Bui Huu H; Ha Thuc N; Thi Le HP; Thi Thanh TD; Luong Bac A; Tiribelli C; Pontisso P; Gallotta A; Paneghetti L; Fassina G Scand J Clin Lab Invest; 2018 May; 78(3):204-210. PubMed ID: 29381084 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038 [TBL] [Abstract][Full Text] [Related]
10. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients. Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis. Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434 [TBL] [Abstract][Full Text] [Related]
12. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma. Koyama N; Yamazaki T; Kanetsuki Y; Hirota J; Asai T; Mitsumoto Y; Mizuno M; Shima T; Kanbara Y; Arai S; Miyazaki T; Okanoue T J Gastroenterol; 2018 Jun; 53(6):770-779. PubMed ID: 29086016 [TBL] [Abstract][Full Text] [Related]
14. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer: A Phase III Study. Maddalo G; Fassan M; Cardin R; Piciocchi M; Marafatto F; Rugge M; Zaninotto G; Pozzan C; Castoro C; Ruol A; Biasiolo A; Farinati F J Clin Gastroenterol; 2018; 52(5):401-406. PubMed ID: 28422774 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis. Yu J; Wang ZJ; Chen LH; Dong WZ Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143 [TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study. Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642 [TBL] [Abstract][Full Text] [Related]
17. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225 [TBL] [Abstract][Full Text] [Related]
18. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis. Cagnin M; Biasiolo A; Martini A; Ruvoletto M; Quarta S; Fasolato S; Angeli P; Fassina G; Pontisso P Sci Rep; 2019 Dec; 9(1):20126. PubMed ID: 31882893 [TBL] [Abstract][Full Text] [Related]
19. Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants' serum levels in anti-HCV positive cirrhotic patients. Giannini EG; Basso M; Bazzica M; Contini P; Marenco S; Savarino V; Picciotto A J Viral Hepat; 2010 Aug; 17(8):563-8. PubMed ID: 19840364 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]